Please login to the form below

Evotec

This page shows the latest Evotec news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Another next-gen diabetes research deal for Novo, Vertex and Australia break deadlock

terms. The Copenhagen-headquartered firm has unveiled a series of deals in its core diabetes and metabolic disease area recently, including a research collaboration with Evotec and the acquistion of a

Latest news

Novo Nordisk and Evotec inks drug development deal

Evotec’s part in this new deal will see the biotech apply its drug discovery platform, especially in ligand-based design, to create novel, safe and efficacious products. ... Novo on the other hand, will take advantage of Evotec’s INDiGO platform to
Daily Brief: DeepMind and NHS success in AI, Bayer invests in COPD, Alecensa OK in Scotland

As part of the collaboration, Bayer receives an exclusive licence to worldwide rights to programmes developed by Haplogen and Evotec. ... Undisclosed upfront payment and potential milestone and royalty-based payments will also be paid by Haplogen to
Sanofi poaches Peugeot's finance head

On top of this, Sanofi is also re-shaping its pipeline after it made a deal to transfer its anti-invectives unit to biotech Evotec.
Evotec says Sanofi deal makes it anti-infectives powerhouse

the unit to become an open science focal point – bringing together other “companies, foundations, academia, and government agencies,” says Evotec. ... That essentially means getting other research groups to put drug candidates through Evotec’s
Daily Brief: Gottlieb sets out cell and gene pathway, NICE says no to Chiesi ultra-rare treatment and more

BIG BIOTECH. Celgene expands drug discovery alliance with Evotec. Celgene is experiencing a rollercoaster 2018, with late-stage drug setbacks, the departure of senior executives, and investor pressure to improve its ... Evotec has built a reputation for

More from news
Approximately 12 fully matching, plus 22 partially matching documents found.

Latest Intelligence

Pharma deals continue to slide

For example, Evotec, the German small molecule development company, is acquiring for $300m the US preclinical development company, Aptuit. ... 400. Aptuit (US). Evotec (DE). Company acquisition. Drug discovery and development to IND submission including
Deal Watch December 2016

320. Evotec (Germany). Celgene (US). Discovery collaboration. Induced pluripotent stem cells for neurodegenerative diseases. ... upfront. And although the upfronts are a modest percentage of the headline figure, ranging from < 1% (BioInvent) to 15%
Pharma deals in August 2015

Acquisition of Priority Review Voucher. 350. Evotec. Sanofi. Beta cell modulating treatments for diabetes. ... Acquisition ‐ company. 300. Aperion Biologics Evotec. Sanofi. To develops mall molecule immuno‐therapies.
Deal Watch table for December 2014

Company acquisition. 375. Evotec / Sanofi. R&D alliance to progress Sanofi discovery phase compounds to preclinical stage (inc Sanofi discovery facility with 200 scientists).
Deal Watch table for November 2013

130. Evotec /Janssen. R&D collaboration. Target AD collaboration to identify novel therapies for Alzheimer's.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

Apitope strengthens its board with new director

He has also served on several boards including Ablynx, Evotec and Acambis.
Evotec CEO Werner Lanthaler temporarily stands down

Cites health reasons. Evotec's CEO Dr Werner Lanthaler, has temporarily stood down from his role within the company due to health reasons.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Manager / Senior Account Manager: 35, 000-40, 000

Account Director: Competitive Salary Offered

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

Account Director – Health Policy – Global Agency: Salary TBC

Senior Medical Writer: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Medical Writer: Salary TBC

Senior Account Director development role to Business Director, H...: Excellent package

Account Director, Healthcare Marketing Agency: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Account Manager / Account Director: Competative

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Senior Account Manager: Competitive Salary Offered

Client Services Director – Medical Education Agency – North West...: Salary TBC

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Associate Director: £75, 000-90, 000

Business Director: Competitive Salary Offered

Account Director, Medical Education: Salary TBC

Global Business Development Director – Health Education: excellent commission

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Account Director – Healthcare Marketing – Berks: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

NHS regional footprints: What to expect from 2019...
Not another weight-loss ad: Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up: As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...